ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML

Clinical trial NCT05622591 · WITHDRAWN

Trial details

NCT number: NCT05622591
Sponsor: Elucida Oncology
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia AML, Childhood Relapsed Pediatric AML Refractory Pediatric AML

Start date: 2024-06-07
Primary completion: 2024-06-07
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.